Table 5.

Association of antithrombotic treatment with intraplaque haemorrhage, according to international normalized ratios for vitamin K antagonists and daily defined dosage for antiplatelet agents

	IPH, OR (95% CI)
Vitamin K antagonists
INR
≤2.68	1.56 (0.94–2.56)
2.69–2.97	1.54 (0.93–2.54)
>2.97	1.48 (1.03–2.15)
Antiplatelet agents
DDD
≤0.99	0.71 (0.29–1.76)
1.00–1.99	1.50 (1.21–1.87)
>2.00	2.24 (1.03–4.87)

Values are adjusted for age and sex.

CI, confidence interval; INR, international normalized ratio; IPH, intraplaque haemorrhage; OR, odds ratios.